| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |